Study reveals key bacteria in healthy gut microbiomes

Researchers have identified 50 bacterial species strongly associated with markers of good health in the gut microbiome, based on data from over 34,000 people. The findings highlight links to cholesterol control, reduced inflammation, and better blood sugar management. This work aims to define what constitutes a healthy microbial community amid ongoing debates over its composition.

A large-scale analysis of gut microbiomes from more than 34,500 participants in the PREDICT program, conducted in the UK and US by Zoe, has pinpointed specific bacteria tied to health outcomes. The study, published in Nature, focused on 661 bacterial species present in over 20 percent of participants. Among these, 50 species—22 newly identified—correlate with positive health indicators, including lower cholesterol levels, reduced inflammation, healthier immune function, better body fat distribution, and improved blood sugar control.

Healthy individuals without known medical conditions hosted about 3.6 more of these beneficial species compared to those with conditions. Similarly, people at a healthy weight had roughly 5.2 more such species than those with obesity. The research suggests these microbes influence health by producing chemicals that aid cholesterol transport, curb inflammation, metabolize fats, and enhance insulin sensitivity.

Most of the beneficial and harmful bacteria belong to the Clostridia class, particularly the Lachnospiraceae family, with 13 species showing favorable effects and 27 unfavorable ones. Nicola Segata at the University of Trento in Italy, who led the work, noted: “There is a very intricate relationship between the food we eat, the composition of our gut microbiome and the effects the gut microbiome has on our health. The only way to try to map these connections is having large enough sample sizes.”

Dietary patterns were also examined through questionnaires and Zoe app data, recommending at least 30 different plants weekly, three daily portions of fermented foods, high fiber intake, and minimal ultra-processed items. While most microbes aligned with healthier or poorer diets, 65 did not, underscoring the complexity. Segata added: “These 65 bacteria are a testament to the fact that the picture is still more complex than what we saw.”

The team developed a 0-to-1000 scale to rank gut microbiome health, now integrated into Zoe's tests. Tim Spector at King’s College London, a co-founder of Zoe, explained: “Think of a healthy gut microbiome as a community of chemical factories. We want large numbers of species, we want the good ones outnumbering the bad ones, and when you get that, then you’re producing really healthy chemicals, which have impacts across the body.”

Experts like Ines Moura at the University of Leeds caution that defining a healthy microbiome remains challenging due to influences from diet, environment, age, and medications. Larger global studies are needed to refine these insights and potentially guide personalized dietary recommendations.

Liittyvät artikkelit

Scientists in a lab studying how common chemicals disrupt human gut bacteria, with a machine learning model screen showing risk predictions.
AI:n luoma kuva

Scientists identify everyday chemicals that disrupt human gut bacteria

Raportoinut AI AI:n luoma kuva Faktatarkistettu

Researchers at the University of Cambridge have found that 168 common industrial and agricultural chemicals can harm beneficial bacteria in the human gut, with some also promoting resistance to antibiotics. Drawing on a large laboratory screen, the team created a machine learning model to predict which chemicals may pose risks to the microbiome.

Researchers have discovered a unique oral microbiome signature in people with obesity, potentially offering early detection and prevention strategies. The finding, based on saliva samples from Emirati adults, highlights differences in bacteria and metabolic pathways associated with metabolic dysfunction. However, scientists caution that the relationship's causality remains unclear.

Raportoinut AI

Scientists at Flinders University have developed the first database tracking beneficial microbes and natural compounds that support human health. The 'Database of Salutogenic Potential' highlights how exposure to diverse environmental microbiomes can boost immune strength and reduce stress. This work challenges the traditional focus on pathogens and promotes a balanced view of microbial biodiversity.

Researchers have discovered that common food emulsifiers consumed by mother mice can disrupt their offspring's gut microbiome from early life, increasing risks of inflammation, gut disorders, and obesity later on. The study, conducted at Institut Pasteur and Inserm, highlights potential generational health impacts without direct exposure. Findings were published in Nature Communications.

Raportoinut AI

A new study reveals that chemotherapy's damage to the gut lining unexpectedly rewires the microbiota, producing a compound that strengthens immune defenses against cancer spread. This process reduces immunosuppressive cells and enhances resistance to metastasis, particularly in the liver. Patient data links higher levels of this compound to improved survival in colorectal cancer cases.

Recent research shows that body fat is more than a calorie store; it actively regulates immune responses and blood pressure. Scientists have identified specialized fat depots near the intestines that coordinate immunity against gut microbes, while another study links beige fat around blood vessels to vascular health. These findings challenge simplistic views of fat as merely harmful.

Raportoinut AI

Scientists at the University of Basel have developed a novel testing method to determine whether antibiotics actually eliminate bacteria or merely halt their growth. This approach, called antimicrobial single-cell testing, tracks individual bacteria under a microscope to assess drug effectiveness more accurately. The findings, published in Nature Microbiology, highlight variations in bacterial tolerance to treatments for tuberculosis and other lung infections.

 

 

 

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää